[go: up one dir, main page]

Micklem et al., 1984 - Google Patents

Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2)

Micklem et al., 1984

View PDF
Document ID
9581071049414999469
Author
Micklem K
Sim R
Sim E
Publication year
Publication venue
Biochemical Journal

External Links

Snippet

The rosetting of defined C3-fragment-coated sheep erythrocytes to B-cell-enriched tonsil lymphocytes was measured. The rosetting lymphocytes were homogeneous with respect to expression of C3b, iC3b and C3d receptors. Isolation of receptors for C3 fragments from …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody

Similar Documents

Publication Publication Date Title
Ballow et al. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them
Podack et al. The SC5b-7 complex: formation, isolation, properties, and subunit composition
Muldoon et al. Steroid-protein interactions: XV. Isolation and characterization of corticosteroid-binding globulin from human plasma
Inganäs et al. Interaction of human polyclonal IgE and IgG from different species with protein A from Staphylococcus aureus: demonstration of protein‐A‐reactive sites located in the Fab2 fragment of human IgG
Schlossman et al. Specific fractionation of a population of antidextran molecules with combining sites of various sizes
Podack et al. The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum
Micklem et al. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150, 95 as an iC3b-binding protein
Yasmeen et al. The Structure and Function of Immunoglobulin Domains: IV. The Distribution of Some Effector Functions Among the Cγ2 and Cγ3 Homology Regions of Human Immunoglobulin G
Russell et al. Role of serum IgA. Hepatobiliary transport of circulating antigen.
Arnaout et al. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
Cerra et al. Three soluble rat beta-galactoside-binding lectins.
Micklem et al. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2)
Gilman et al. Symmetrical distribution of genetic markers in individual rabbit γ-globulin molecules
Plow et al. Isolation and characterization of a homogeneous isomeric species of carcinoembryonic antigen: CEA‐S
Reid et al. Structural relationships between human erythrocyte sialoglycoproteins β and γ and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen (s)
Daha et al. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus
Götze et al. Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin
Klug et al. Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose II (CA 19-9)
Lindgren et al. IgM in primary biliary cirrhosis: physicochemical and complement activating properties
Harboe et al. Individual antigenic specificity of human macroglobulins: Localization of antigenic determinants and their use to demonstrate formation of hybrid molecules after reduction and reassociation
Cierniewski et al. Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its γ-γ chain remnant
Kosaka et al. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor
Kaidoh et al. Murine C4-binding protein: a rapid purification method by affinity chromatography.
Eggert The Nature of Secretory Agglutinins and Aggregating Factors: IV. Complexing between Non-Mucin Glycoproteins, Immunoglobulins and Mucins in Human Saliva and Amniotic Fluid
Von Schenck et al. Interference of immunoglobulins in two glucagon radioimmunoassays.